Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GSK2126458 has the potential to inhibit the proliferation of pancreatic cancer uncovered by bioinformatics analysis and pharmacological experiments

30 Aug 2021

Abstract excerpt

BACKGROUND: Pancreatic cancer is one of the most serious digestive malignancies. At present, there is an extreme lack of effective strategies in clinical treatment. The purpose of this study is to identify key genes and pathways in the development of pancreatic cancer and provide targets for the treatment of pancreatic cancer. METHODS: GSE15471 and GSE62165 were used to screen differentially expressed genes by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to FOXO transcription factor regulation
Share to Pancreatic and Hepatic Oncology Research
Share to PI3K/AKT/mTOR signaling in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34461940
DOI: 10.1186/s12967-021-03050-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GSK2126458 has the potential to inhibit the proliferation of pancreatic cancer uncovered by bioinformatics analysis and pharmacological experimentsPMID 34461940Read ↗

Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysisSemantic proximity Read ↗

Integrated bioinformatics analysis of potential biomarkers for pancreatic cancerSemantic proximity Read ↗

Identification of key hub genes in pancreatic ductal adenocarcinoma: an integrative bioinformatics studySemantic proximity Read ↗

Identification of Key Genes and Pathways in Pancreatic Cancer Gene Expression Profile by Integrative AnalysisSemantic proximity Read ↗

Identification of novel candidate biomarkers and efficacious small molecule drugs for pancreatic adenocarcinoma based on comprehensive bioinformatics technologySemantic proximity Read ↗

An integrative mutational and network analysis of pancreatic cancer reveals key genes, and signalling pathways.Semantic proximity Read ↗

Identification of potential target genes in pancreatic ductal adenocarcinoma by bioinformatics analysisSemantic proximity Read ↗

ITGA2, LAMB3, and LAMC2 May Be the Potential Therapeutic Targets in Pancreatic Ductal Adenocarcinoma: an Integrated Bioinformatics AnalysisSemantic proximity Read ↗

ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysisSemantic proximity Read ↗

A Genome-scale CRISPR Screen Identifies the ERBB and mTOR Signaling Networks as Key Determinants of Response to PI3K Inhibition in Pancreatic CancerSemantic proximity Read ↗

Network pharmacology, single gene survival analysis and molecular docking to study the mechanism of Sotetsuflavone in the treatment of pancreatic cancerSemantic proximity Read ↗

RNA binding protein Pumilio2 promotes chemoresistance of pancreatic cancer via focal adhesion pathway and interacting with transcription factor EGR1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.